3 10, 2024

Chevron, ExxonMobil, and Other Energy Stocks are Climbing on Middle East Conflict: Is it Time to Buy?

By |2024-10-03T16:19:12+00:00October 3rd, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , |

It’s like clockwork. Anytime there’s tension in the Middle East it poses a threat to the world’s oil supply, and prices surge accordingly. That’s what we’re seeing this morning for energy stocks like Chevron (CVX) and ExxonMobil (XOM). These stocks are up nearly 6% and 7% respectively in the past week, and they’re up [...]

2 10, 2024

Nike Falls 6% on Dwindling Sales and Profits in Q1 With Weak Guidance for Q2: Is it Time to Sell NKE?

By |2024-10-02T16:58:06+00:00October 2nd, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , |

Nike Inc. (NKE) is down roughly 6% Wednesday morning after the company’s earnings day Tuesday left much to be desired in the eyes of investors.  The company is still struggling to regain its footing, and after withdrawing its full-year guidance, it’s clear that the road ahead will continue to be rocky. Here’s how the [...]

1 10, 2024

Stellantis Shares Fall Amidst Forecast Cuts: While it May Be Time for Investors to Sell STLA

By |2024-10-01T17:54:39+00:00October 1st, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , , , |

Shares of Stellantis NV (STLA) are down 11% in the past week as the Netherlands-based automaker was forced to lower its full-year forecast as costs are climbing while production is falling. The company was originally expecting to deliver a double-digit profit percentage for the fiscal year, but now, the profit guidance has been brought [...]

30 09, 2024

Bristol Myer Stock Gets a Bump on FDA Approval for Schizophrenia Drug: Is it Time to Buy BMY?

By |2024-09-30T17:18:22+00:00September 30th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , |

Late last week Bristol Myers Squibb (BMY) got a nice 8% boost after sharing news that it gained approval from the Food and Drug Administration (FDA) for its schizophrenia drug.  The stock has cooled off since and is up just shy of 4% over the past week, but it has been on a serious [...]

27 09, 2024

Accenture Gains Nearly 6% on Rising Demand for AI Solutions: 2 Other Reasons It’s Time to Buy ACN

By |2024-09-27T15:57:42+00:00September 27th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , , , |

Shares of Accenture (ACN) are up just under 6% in the past week amidst hype for the company’s AI-powered performance in the fourth quarter.  The business management consultant posted adjusted earnings per share of $2.79, which matched the analyst consensus. Revenue of $16.41 billion was a 2.6% improvement year over year and ahead of [...]

26 09, 2024

Snowflake is Sinking After Announcing $2 Billion Debt Plan: Should Investors Be Concerned?

By |2024-09-26T15:59:18+00:00September 26th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , , |

Shares of Snowflake Inc. (SNOW) are down roughly 2% Thursday morning, making it a 6% loss over the past month. The latest bit of downward pressure can be attributed to the company’s announcement that it will be raising $2 billion in debt. The plan involves two separate $1 billion Senior Convertible Notes, one of [...]

25 09, 2024

GM Takes a Dip After Former Bull Downgrades the Stock: 3 Things Investors Need to Know About GM

By |2024-09-25T17:25:15+00:00September 25th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , |

Shares of General Motors Co. (GM) are down more than 5% so far Wednesday morning, making for a 7% loss over the past month. This comes on the heels of a once-bullish analyst changing his stance on the stock, downgrading it from the equivalent of buy to hold. Daniel Roeska with Bernstein moved his [...]

24 09, 2024

Deere & Co. is Up 4% After Trump’s Tariff Threat: 2 More Reasons to Buy DE Today

By |2024-09-24T16:34:23+00:00September 24th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , |

Former US President and current candidate Donald Trump made it clear that American manufacturing is a priority for his platform. He just threatened to slap Deere & Co. (DE) with a 200% tariff should they go through with their plans to move manufacturing to Mexico - provided he wins the election, of course.  Deere [...]

23 09, 2024

Radcom Rallies 5% This Week on Strong Demand – But is it Worth Buying RDCM Today?

By |2024-09-23T18:29:07+00:00September 23rd, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , |

Shares of Radcom Ltd. (RDCM) climbed nearly 15% last week, and while we’ve seen a slight reversal after the weekend, the stock is still up more than 5% in the past 7 days. This comes after the company noted that it saw an uptick in demand for a wide array of product offerings. Its [...]

20 09, 2024

FedEx Falls Hard After Lowering Guidance: Here’s Why it May Be Time to SELL FDX

By |2024-09-20T16:38:32+00:00September 20th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , |

FedEx (FDX) shared fiscal first-quarter results yesterday after the market closed, but it was the lowered guidance that really sent ripples through the market. The stock is down 14% so far Friday. Here’s how the company performed in Q1: Earnings: $3.60 per share compared to the consensus of $4.75 per share. Revenue: $21.6 billion [...]

Go to Top